TARID and coronary artery disorder: TARID was identified as an eQTL target gene in human coronary artery smooth muscle cells (108), and molecular studies suggest this lncRNA guides GADD45A mediated DNA demethylation and inactivation of TCF21 (109), a known tumor suppressor and vascular wall transcription factor associated with CAD (110–113).